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dult multipotent neural progenitor cells can differ-
 
entiate into neurons, astrocytes, and oligodendrocytes
in the mammalian central nervous system, but the
molecular mechanisms that control their differentiation are
not yet well understood. Insulin-like growth factor I (IGF-I)
can promote the differentiation of cells already committed
to an oligodendroglial lineage during development. How-
 
ever, it is unclear whether IGF-I affects multipotent neural
progenitor cells. Here, we show that IGF-I stimulates the dif-
ferentiation of multipotent adult rat hippocampus-derived
A
 
neural progenitor cells into oligodendrocytes. Modeling
analysis indicates that the actions of IGF-I are instructive.
 
Oligodendrocyte differentiation by IGF-I appears to be me-
diated through an inhibition of bone morphogenetic protein
signaling. Furthermore, overexpression of IGF-I in the hip-
pocampus leads to an increase in oligodendrocyte mark-
 
ers. These data demonstrate the existence of a single
molecule, IGF-I, that can inﬂuence the fate choice of
multipotent adult neural progenitor cells to an oligoden-
droglial lineage.
 
Introduction
 
Multipotent cells with the ability to divide and differentiate
have been shown to exist throughout the central nervous
system (CNS), yet neurogenesis appears to be restricted to
two specific brain regions within the adult CNS: the subven-
tricular zone and the hippocampal subgranular zone (Gage,
2000). Beyond these two regions, most of the dividing cells
in other areas give rise to new glial cells and not neurons
(Horner et al., 2000; Kornack and Rakic, 2001; Rakic,
2002). However, when these dividing cells are isolated from
different regions of the CNS (Reynolds and Weiss, 1992;
Lois and Alvarez-Buylla, 1993; Palmer et al., 1997), including
nonneurogenic areas (Shihabuddin et al., 1997; Palmer et al.,
1999; Kondo and Raff, 2000), they all retain the ability to
self-renew and differentiate into neurons, oligodendrocytes,
and astrocytes in culture. Remarkably, even proliferating cells
isolated from nonneurogenic areas can differentiate into
neurons when transplanted back into the hippocampus
(Suhonen et al., 1996; Shihabuddin et al., 2000), suggesting
that cues from the local environment influence their fate
determination and differentiation programs.
Recent work by Song et al. (2002) directly examined
the idea that different environments can influence the fate
specification of neural stem cells. Astrocytes from neurogenic
regions (but not nonneurogenic regions) can preferentially
direct multipotent adult neural stem cells to differentiate
into neurons. Interestingly, these neural stem cells appear to
 
preferentially differentiate into oligodendrocytes when cultured
together with hippocampus-derived neurons. These results
suggest that specific signals from different CNS environ-
ments exist for lineage-specific differentiation. Examples of
extrinsic factors important for neuronal and astroglial differ-
entiation of multipotent adult neural stem cells have already
been identified (Takahashi et al., 1999; Lim et al., 2000;
Tanigaki et al., 2001). However, little is known regarding
the control of oligodendrocyte differentiation of multipotent
adult neural stem cells.
Insulin-like growth factors (IGFs) comprise one class of
molecules that have effects on oligodendrocyte biology during
development (D’Ercole et al., 1996). IGFs (IGF-I, IGF-II)
and insulin can all independently promote the survival of
purified oligodendrocytes in culture (Barres et al., 1993).
Furthermore, IGFs have important roles in the proliferation
and differentiation of cells that have already committed to
an oligodendroglial lineage during development (McMorris
et al., 1986; McMorris and Dubois-Dalcq, 1988). In addition,
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transgenic and knockout mouse models have revealed in
vivo effects of IGFs on oligodendrocyte development and
myelination. Overexpression of IGF-I in transgenic mice re-
sults in increased brain size and myelin content (Carson et
al., 1993; Ye et al., 1995). Conversely, IGF-I knockout mice
have smaller brains, reduced oligodendrocyte numbers, and
CNS hypomyelination (Baker et al., 1993; Carson et al.,
1993; Beck et al., 1995; Ye et al., 2002).
In this paper, we show that IGF-I can preferentially in-
duce the differentiation of multipotent adult neural progeni-
tor cells into oligodendrocytes. Using a modeling approach,
we show that the IGF-I–induced increase in oligodendro-
cyte numbers is attributable to an instructive differentiation
of uncommitted cells to an oligodendroglial fate, not to a se-
lective proliferation or survival of committed oligodendro-
cyte progenitors. The IGF-I–induced oligodendrocyte dif-
ferentiation appears to be mediated, at least in part, by the
inhibition of bone morphogenetic protein (BMP) signaling.
Furthermore, overexpression of IGF-I in the hippocampus
led to an increase in immunoreactivity for oligodendrocyte
markers. These results provide evidence that IGF-I is an im-
portant regulator of oligodendrocyte differentiation from
multipotent adult neural progenitor cells.
 
Results
 
IGF-I–induced oligodendrocyte differentiation
 
First, we tested the action of exogenous IGF-I on the differ-
entiation of hippocampus-derived adult neural progenitor
cells. These neural progenitor cells have stem cell properties
in vitro: (1) they self-renew in the presence of basic FGF-2;
(2) single genetically marked clones can differentiate into all
three main CNS cell types in vitro (neurons, oligodendro-
cytes, and astrocytes) and when grafted back to adult hippo-
campus in vivo; and (3) they express progenitor cell markers
such as nestin, but lack markers of lineage-specific differenti-
ation (Fig. 1 A; Gage et al., 1995; Palmer et al., 1997). To
confirm that the adult neural progenitor cell population in
our model system is indeed multipotent, we first used vari-
ous standard differentiation paradigms and evaluated the ex-
Figure 1. IGF-I–induced differentiation of multipotent neural progenitor cells. (A) Adult hippocampus-derived neural progenitor cells 
cultured in insulin-containing N2 media with 20 ng/ml FGF-2 (undifferentiated), 1  M RA, and 1% FBS for 4 d (mixed), 1  M RA and 5  M 
forskolin for 4 d (neuronal), or 50 ng/ml leukemia inhibitory factor and 50 ng/ml BMP2 for 6 d (astrocytic). Cells were stained for markers for 
neurons (Tuj1), astrocytes (GFAP), or oligodendrocytes (RIP), and also with DAPI. Bar, 50  m. (B) Differentiation of neural progenitor cells in 
insulin-free N2 media without IGF-I (control) or with IGF-I for 4 d. Insets show cells of typical oligodendrocyte morphology stained with RIP 
or MBP. Bar, 25  m. (C) Quantification of cells in either proliferating or differentiating conditions. (D) Quantification of cultures grown in in-
sulin-free N2 media (control) or treated with 500 ng/ml IGF-I, IGF-II, or insulin after 4 d. (E) Quantification of cells in response to different doses 
of IGF-I (20–500 ng/ml) in 4-d cultures. All data shown are from at least three experiments in parallel cultures with error bars representing SDs. 
Significant differences are indicated with an asterisk (P   0.005). 
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pression of lineage markers. Differentiation with 1 
 
 
 
M reti-
noic acid (RA) and 1% FBS resulted in mixed numbers of
Tuj1
 
 
 
 neurons, GFAP
 
 
 
 astrocytes, and RIP
 
 
 
 oligodendro-
cytes (Fig. 1 A). Neuron-enriched differentiation can be
achieved with 1 
 
 
 
M RA and 5 
 
 
 
M forskolin (Chu, V., per-
sonal communication), and astrocyte-enriched differentia-
tion with 50 ng/ml leukemia inhibitory factor and 50 ng/ml
BMP2 (Fig. 1 A; Nakashima et al., 1999). The quantifica-
tion of lineage-specific differentiation is also shown (Fig. 1
C). These results are in agreement with previous reports
(Palmer et al., 1997), and indicate that the majority of the
adult neural progenitor cells within the bulk population are
multipotent progenitors, and not restricted neuronal or glial
progenitors.
To determine the effects of IGF-I on neural progenitor cell
differentiation, we compared cells treated with and without
IGF-I over a 4-d period. All experiments were performed in
insulin-free N2 medium to avoid its actions on insulin and/
or IGF-I receptors. When FGF-2 was withdrawn from neural
progenitor cells and the cells were cultured in the absence of
insulin for 4 d, lineage-specific differentiation was not seen
(Fig. 1 B). There was also a dramatic decrease in cell survival,
consistent with the important effects of IGFs for preventing
cell death (Vincent and Feldman, 2002). We found that neu-
ral progenitor cells cultured in the presence of 500 ng/ml
IGF-I differentiated into a large percentage of RIP
 
 
 
 cells
(
 
 
 
45–55%; Fig. 1, B and D). RIP is a marker for both im-
mature and mature oligodendrocytes, in that it stains pre-
ensheathing oligodendrocytes through myelinating stages
and associated myelin (Friedman et al., 1989). In addition to
RIP staining, these cells exhibited small and round somata
with the characteristic weblike oligodendrocyte morphology
within 4 d (Fig. 1 B). Approximately 23% of the total cells
were also positive for myelin basic protein (MBP), a late-
appearing marker for myelinating oligodendrocytes (Akiyama
et al., 2002), at the 4-d time point (Fig. 1 B).
Furthermore, 500 ng/ml IGF-II or insulin could also pro-
mote the preferential differentiation of neural progenitor
cells into oligodendrocytes (Fig. 1 D). The IGF-mediated
oligodendrocyte differentiation is likely to occur through an
activation of IGF-I receptors; addition of IGF-I, IGF-II,
or insulin at different concentrations (20–1,000 ng/ml)
showed a rank order of potency IGF-I 
 
  
 
IGF-II 
 
  
 
insulin,
which is consistent with the pharmacology of the IGF-I re-
ceptor (LeRoith et al., 1993). RT-PCR analysis showed
IGF-I receptor mRNA expression in neural progenitors (un-
published data). There was also a small percentage of neural
progenitor cells that differentiated into Tuj1
 
 
 
 neurons (
 
 
 
5–
15%) with IGF-I or -II or insulin treatment (each at 500 ng/
ml), with few to no GFAP
 
 
 
 astrocytes (Fig. 1 D). The IGF-
I–induced oligodendrocyte differentiation occurred in a
dose-dependent manner, whereas the percentage of Tuj1-
positive cells did not appear to change at any of the tested
concentrations (Fig. 1 E).
The severe and rapid death of neural progenitor cells cul-
tured in the absence of IGF-I left open the possibility that
FGF-2 withdrawal alone could be promoting oligodendro-
cyte differentiation and that the addition of IGF-I merely
promoted oligodendrocyte survival. To address this issue, we
kept neural progenitor cells alive with the broad caspase in-
hibitor Q-VD-OPh (Caserta et al., 2003), and assessed neu-
ral progenitor differentiation with and without IGF-I in 2-d
cultures (Fig. 2, A–C). Neural progenitors that differenti-
ated into definitive oligodendrocytes were scored on the
basis of morphological criteria (elaboration of weblike
processes), as well as immunoreactivity with various oligo-
dendrocyte markers (O4, NG2, RIP, and MBP). In the ab-
sence of Q-VD-OPh in insulin-free N2 medium, there was
decreased cell survival, evidenced by the presence of frag-
mented DAPI-stained nuclei and a general disappearance of
cells. Addition of 2 
 
 
 
M Q-VD-OPh to the cells promoted
the majority of the cells to survive, as seen by smooth DAPI-
stained nuclei and a general persistence of cells in 2-d cul-
tures, without obvious effects on proliferation or differentia-
tion (Fig. 2, A and B). The absolute number of cells does
not significantly change in Q-VD-OPh-treated cultures
compared with cells just after plating (unpublished data).
Although the cells exhibited some degree of O4 and RIP
staining in the soma, only a small number of cells (
 
 
 
2–4%)
Figure 2. IGF-I–mediated increase in oligodendrocyte differentiation 
is independent of effects on neural progenitor cell survival in 2-d 
cultures. (A) Treatment of cells with 2  M Q-VD-OPh resulted in a 
general absence of apoptosis in short-term cultures. The maintenance 
of cell survival is shown by a general persistence of cells and a lack 
of fragmented DAPI-stained nuclei, without obvious effects on cell 
proliferation or differentiation. Addition of 500 ng/ml IGF-I to the 
Q-VD-OPh–treated cultures mediated an increase in oligodendrocyte 
differentiation, as evidenced by O4 staining and morphological 
criteria. (B) Similar results were seen with RIP. (C) Quantification of 
O4 and RIP
  oligodendrocytes. Bar, 25  m. 
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exhibited both staining and morphological criteria indicative
of a differentiated oligodendrocyte in Q-VD-OPh–treated
cultures. This finding is presumably due to spontaneous dif-
ferentiation upon FGF-2 withdrawal. In addition, we did
not detect MBP staining in Q-VD-OPH–treated cultures,
further confirming that FGF-2 withdrawal alone could not
promote the robust differentiation and maturation of a mul-
tipotent neural progenitor cell into a definitive oligodendro-
cyte. Only when neural progenitors were cultured with 500
ng/ml IGF-1 did we observe a large increase in O4 and
RIP
 
 
 
 cells with the characteristic weblike morphology in 2-d
cultures (Fig. 2, A and B). The quantification of oligoden-
drocyte differentiation is also shown (Fig. 2 C). The pres-
ence of NG2
 
 
 
 cells was not observed in Q-VD-OPh–treated
cultures, with or without IGF-I, suggesting that adult multi-
potent neural progenitor cells do not transition through an
NG2
 
 
 
 cell upon IGF-I stimulation. These data suggest that
IGF-1 can directly induce multipotent neural progenitor
cells to differentiate into oligodendrocytes, instead of merely
promoting the survival of differentiated oligodendrocytes.
The oligodendrocyte-promoting effects of IGF-I were con-
firmed with an independently derived rat hippocampus pro-
genitor cell line, as well as a clonally derived line (unpublished
data). Furthermore, early-passaged cultures (
 
 
 
5) of multipo-
tent neural progenitor cells derived from the whole brain of
P10 ICR mice also exhibited a preferential differentiation
into oligodendrocytes upon IGF-I treatment (unpublished
data). These data suggest that IGFs (IGF-I and -II) and insu-
lin, through an activation of IGF-I receptors, are important in
stimulating the differentiation and maturation of multipotent
adult neural progenitor cells into oligodendrocytes.
 
IGF-I–induced increase in oligodendrocytes is 
attributable to an instructive differentiation and a 
subsequent proliferation of committed oligodendrocytes
 
Although these results establish IGF-I as an inducer of oligo-
dendrocyte differentiation for a population of multipotent
neural progenitor cells, it is more complicated to quantita-
tively assess the instructive versus selective effects of IGF-I.
Therefore, we determined whether the increase of oligoden-
drocytes after IGF-I treatment could be due to a combina-
tion of selective oligodendrocyte survival, increased prolifer-
ation of progenitors, and/or instructive differentiation of
progenitor cells to an oligodendroglial lineage. First, we di-
rectly measured the effect of IGF-I on cell survival. We
asked whether a selective decrease in the death of oligoden-
drocytes (and/or oligodendrocyte progenitors) could explain
the net increase in number of oligodendrocytes (defined by
the expression of RIP, a marker of both immature and ma-
ture oligodendrocytes). If IGF-I had a selective survival ef-
fect on oligodendrocytes and/or their progenitors, we would
expect to see a change in cell death due to the increased
death of other cell types. To quantify cell death of the prog-
eny of neural progenitor cells, living cultures were stained
with 1 
 
 
 
g/ml propidium iodide, which stains dead cells, and
1 
 
 
 
g/ml Hoechst 33342, which stains live and dead cells.
Staining of live (rather than fixed) cultures was used to avoid
underestimating cell death due to possible detachment of
dying and/or dead cells from culture substrates. This as-
say revealed a relatively small percentage of dead/dying
cells, and one-way ANOVA analysis revealed no significant
change (P 
 
  
 
0.3930) in the percentage of cells that died at
any of the time points (Fig. 3 A). The amount of cell death
in IGF-I–treated cultures was similar to the amount of cell
death under standard proliferating conditions with FGF-2
(unpublished data). Cultures grown in the absence of IGF-I
exhibited a progressive increase in overall cell death, rein-
forcing the role of IGF-I as an important factor for cell sur-
vival. Because there was minimal death and no significant
difference in the percentage of dead/dying cells at each of the
time points in the IGF-I–treated cultures, a selective survival
of oligodendrocyte progenitors or oligodendrocytes does not
appear to have a significant role in the increased net oligo-
dendrocyte differentiation with IGF-I treatment.
Next, we determined whether proliferation of progenitors
might contribute to the observed increase in oligodendro-
cyte differentiation. 2.5 
 
 
 
M BrdU was added to parallel cul-
tures for 12 h at 0, 12, 24, and 36 h after plating, followed
by fixation and quantification of total cell numbers and
BrdU
 
 
 
 cells. We counted the progenitor cells (evidenced by
a lack of RIP staining) that were labeled with BrdU at each
time point. For cells grown in the absence of IGF-I, we ob-
served a progressive decrease in the percentage of cells that
were proliferating (BrdU
 
 
 
) during the 48-h experiments
(Fig. 3 B). There was a marked decrease in proliferation dur-
Figure 3. Effect of IGF-I on the survival, proliferation, and instruc-
tive oligodendrocyte differentiation of adult neural progenitor cells. 
(A) Quantification of cell death in insulin-free (no IGF-I) and IGF-I–
treated (500 ng/ml) cultures, as determined every 12 h by live 
staining with 1  g/ml propidium iodide and 1  g/ml Hoechst 33342. 
(B) Proliferation in insulin-free (no IGF-I) and IGF-I–treated (500 ng/ml) 
cultures as determined by BrdU incorporation. Parallel cultures were 
incubated with 2.5  M BrdU at the beginning of each 12-h time 
point, immediately followed by fixation and BrdU staining. BrdU
  
cells were counted as either being RIP
  (blue and black columns) or 
RIP
  (red columns). All data are from at least three independent 
experiments in parallel cultures with error bars representing SDs. 
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ing the 36- and 48-h periods, probably due to limited cell
survival in the absence of IGF-I. In cultures treated with
IGF-I, the percentage of RIP
 
 
 
 cells that incorporated BrdU
also exhibited a decreasing trend in the first three time peri-
ods, but to a lesser extent compared with the cells grown
without IGF-I (Fig. 3 B, blue columns). This initial decrease
in proliferation is most likely due to FGF-2 mitogen with-
drawal. The fact that we could already observe the genera-
tion of RIP
 
 
 
 oligodendrocytes at the 24-h time point (Fig. 4
C), coupled with the observation that there was a decrease in
BrdU uptake of RIP
 
 
 
 cells, suggests that IGF-I did not have
a major proliferative effect on progenitor cells.
These data taken alone may not be sufficient to fully eval-
uate the effects of IGF-I on proliferation of RIP
 
 
 
 progeni-
tors because if there is also a differentiation effect (conver-
sion of RIP
 
 
 
 to RIP
 
 
 
 cells), a substantial decrease in the
percentage of RIP
 
 
 
 cells that were BrdU
 
 
 
 may be seen.
Therefore, to separate the IGF-I effects on proliferation of
progenitors from the instructive differentiation of progeni-
tors to oligodendrocytes, we developed a mathematical
model (Fig. 4 A). This modeling approach has previously
been used to quantify the effects of hippocampal astrocytes
on the proliferation and neuronal differentiation of adult
neural progenitor cells (Song et al., 2002). To distinguish
the proliferation and differentiation rates, the model re-
quired that we count the number of RIP
 
 
 
 cells that were ei-
ther positive or negative for BrdU at each time point. There
was a progressive increase in the overall number of RIP
 
 
 
cells over time in the presence of IGF-I (Fig. 4 C). We also
stained the cultures at each time point for Tuj1
 
 
 
 neurons
and GFAP
 
 
 
 astrocytes to determine if the model should ac-
count for the differentiation to alternative cell types; because
neuronal differentiation was minimal and astrocyte differen-
tiation was undetectable, these possibilities did not merit in-
clusion into the model. Interestingly, after 24 h, there was
also a significant increase in RIP
 
 
 
 cells positive for BrdU,
Figure 4. IGF-I instructs neural progenitor cells to commit to 
an oligodendroglial lineage and increases the proliferation of 
committed oligodendrocytes. (A) Adult neural progenitor cell 
states in culture:  , proliferation rate of progenitors (RIP
 );  , 
differentiation rate of progenitors (RIP
 ) to oligodendrocytes (RIP
 ); 
 , cell death rate for progenitors (RIP
 );  , proliferation rate for 
oligodendrocytes (RIP
 );  , cell death rate for oligodendrocytes 
(RIP
 ). (B and C) Comparison between direct measurements 
(columns) and modeling analyses (lines) of the total cell numbers 
(B) and of the percentage of RIP
  cells (C). Black columns are 
insulin-free (no IGF-I) conditions, and blue columns are 500 ng/ml 
IGF-I conditions. No significant differences were found between 
the direct measurements and the values predicted by the model 
in each case. All data were normalized to values at the 12-h time 
point within each condition due to variability in cell behavior at time 0 (4 h after plating). (D) The proliferation rates for RIP
  ( ) and RIP
  ( ) 
cells in insulin-free (no IGF-I) conditions (black line) and treated with 500 ng/ml IGF-I (blue and red lines). (E) The differentiation rate for RIP
  
( ) cells treated with 500 ng/ml IGF-I. These data are representative of at least three independent experiments. Error bars (except in D and E) 
represent SDs. The error bars in D and E represent the upper and lower bounds for proliferation ( ,  ) and differentiation ( ) rates. 
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suggesting that committed oligodendrocytes may still be
proliferating in the presence of IGF-I (Fig. 3 B, red col-
umns). Because of this finding, we decided to separate the
proliferation rate of RIP
 
 
 
 (defined as 
 
 
 
) and RIP
 
 
 
 cells (
 
 
 
),
as well as the differentiation rate (
 
 
 
) of RIP
 
 
 
 to RIP
 
 
 
 cells.
The overall death rate measured by Hoechst dye in live cul-
tures could not be experimentally separated into a RIP
 
 
 
death rate (
 
 
 
) and a RIP
 
 
 
 death rate (
 
 
 
; Song et al., 2002).
Therefore, the model was bounded by the two possibilities
that all cell death is from only RIP
 
 
 
 or only RIP
 
 
 
 cells. We
also considered the more probable assumption that the
death rates for both RIP
 
 
 
 and RIP
 
 
 
 cells were equal. Six
equations were used to derive values for these rates. The first
equation describes the differential gain in RIP
 
 
 
 cells:
 
(1)
 
where 
 
N
 
RIP
 
 
 
 is the number of RIP
 
 
 
 cells, 
 
 
 
 is the prolifera-
tion rate of RIP
 
 
 
 cells (per 12-h interval), 
 
 
 
 is the differenti-
ation rate of RIP
 
 
 
 into RIP
 
 
 
 cells, and 
 
 
 
 is the death rate of
RIP
  cells. Similarly for RIP
  cells,
(2)
where N
RIP  is the number of RIP
  cells,   is a prolifera-
tion rate of RIP
  cells, and   is the RIP
  death rate. The
sum of (Eq. 1) and (Eq. 2) is the equation defining total
cell count:
(3)
The time-course experiments were performed in 12-h in-
tervals, allowing for measurement of the proliferation and
differentiation rates at each 12-h time interval;  i is the pro-
liferation rate of RIP
  cells at time “i” and so forth. BrdU up-
take experiments allow for direct measurements of the num-
ber of new cells that were generated within the time interval:
(4)
where #BrdUi   1 is the number of cells that incorporated
BrdU between time “i” and “i 1.” Inspection of BrdU
 
cells that are negative or positive for RIP gives the equations:
(5)
(6)
where the  i[ i/(1    i)]N 
RIP 
i term represents the number
of RIP
  cells that may have divided then differentiated
within the same 12-h interval [probability of differentiation
 i times the 2 i/(1    i) term for probability that the differ-
entiating cell is BrdU
 , with a 1/2 correction for the order
of events]. Because dead cells cannot be accurately separated
into RIP
  and RIP
  cells, the model is fitted under three
possible assumptions: all death is RIP
  (    0); all death is
RIP
  (    0); and the death rates are equal (     ). The
proliferation Eq. 5 and Eq. 6 were solved with the differenti-
ation equation 2 to find values for  i,  i, and  i.
To ensure that the model for oligodendrocyte differentia-
tion accurately represented the biological system, we com-
dN
RIP– dt α (δ ) N
RIP– βN
RIP– – – = ⁄
dN
RIP+ dt γ (ε ) N
RIP+ βN
RIP– + – = ⁄
dN
Total dt α (δ ) N
RIP– γ (ε ) N
RIP+ – + – = ⁄
#BrdUi1 + 2γiN i
RIP+ 2αiN i
RIP– + =
#BrdUi1 +
RIP– 2αiN i
RIP– βi αi [ 1 αi + () ] N i
RIP– ⁄ – =
#BrdUi1 +
RIP+ 2γiN i
RIP+ βi αi [ 1 (α i)]N i
RIP– + ⁄ + =
pared the values predicted by the model for total cell counts
(Eq. 3) and cell differentiation (Eq. 2) to direct measurements
at the time points between 12 h and 2 d. No significant differ-
ences were found between direct measurements (Fig. 4, B and
C, columns) and predicted values (Fig. 4, B and C; lines). The
model-derived values indicated that there was no increase in
the proliferation rate of RIP
  cells ( ) over time, reinforcing
the idea that the increased proliferation rate of oligodendro-
cyte progenitors was not the cause for the net increase in oli-
godendrocyte numbers (Fig. 4 D, blue line). The model does
predict an increase in differentiation rate ( ; Fig. 4 E, blue
line); together with the lack of change in the proliferation rate
( ), this can only be taken to mean an increase in instructive
differentiation of RIP
  to RIP
  cells by IGF-I.
The increase in instructive differentiation by itself is not
enough to account for the conversion of RIP
  to RIP
  cells.
The net increase in RIP
  cells must also include in the ex-
planation an increase in the proliferation rate ( ) of RIP
 
cells (Fig. 4 D, red line). If the   term was set to zero (no
RIP
  proliferation), the model predicted significantly fewer
RIP
  oligodendrocytes than were observed experimentally.
Therefore, the only way to resolve the net increase in oligo-
dendrocyte numbers according to the model is an instructive
differentiation from adult multipotent neural progenitors to
oligodendrocytes and a subsequent proliferation of commit-
ted oligodendrocytes in the presence of IGF-I.
IGF-I–induced oligodendrocyte differentiation is 
mediated through an inhibition of BMP signaling
In the developing vertebrate telencephalon and spinal cord,
BMPs have been shown to act as inhibitory signals for oligo-
dendrocyte fate specification (Gross et al., 1996; Mekki-
Dauriac et al., 2002). Additional analyses have shown that
oligodendrocyte lineage progression requires an active inhi-
bition of BMP signaling (Mabie et al., 1999; Mehler et al.,
2000). To gain insight into the molecular mechanism of
IGF-I–induced oligodendrocyte differentiation, we asked
whether IGF-I effects are mediated through an inhibition of
BMP signaling. First, we tested whether BMPs could inhibit
adult neural progenitor cell oligodendrocyte differentiation.
Addition of BMP2 in the presence of 500 ng/ml IGF-I re-
sulted in a suppression of oligodendrocyte differentiation, as
evidenced by a reduction in RIP
  cells compared with cul-
tures treated with IGF-I alone (Fig. 5, A–C). Similar results
were observed with BMP4 (unpublished data). This inhibi-
tion of oligodendrocyte differentiation is dose-dependent;
higher concentrations of BMP2 (5–50 ng/ml) resulted in
a greater suppression of oligodendrocyte differentiation,
whereas partial differentiation could still be observed at
lower BMP2 concentrations (0.05–0.5 ng/ml; Fig. 5 C).
These results are consistent with the ability of BMPs to re-
press oligodendrocyte differentiation.
BMP signaling can be inhibited by extracellular proteins,
such as Noggin, that bind BMP ligands in a competitive
manner, interfering with the ability of ligand binding to cog-
nate cell surface receptors (Balemans and Van Hul, 2002). If
the IGF-I induction of oligodendrocyte differentiation is
mediated through an inhibition of BMP signaling, the func-
tion of BMP antagonists could be involved. To test the in-
volvement of BMP antagonists, we treated neural progenitorOligodendrocyte differentiation induced by IGF-I | Hsieh et al. 117
cells with different concentrations of IGF-I in conjunction
with exogenous Noggin and compared the extent of oligo-
dendrocyte differentiation to cultures treated with IGF-I
alone (Fig. 5, D–F). When 500 ng/ml Noggin was added to
cultures treated with 20–100 ng/ml IGF-I, there was a sig-
nificant increase in the percentage of oligodendrocytes com-
pared with cultures treated with IGF-I alone (Fig. 5 F; P  
0.05, t test). Addition of 500 ng/ml Noggin together with
highest concentrations of IGF-I (500–1,000 ng/ml) did not
result in a significant change in the percentage of RIP
  oli-
godendrocytes compared with IGF-I alone (Fig. 5 F), pre-
sumably due to saturating effects of IGF-I. Next, we wanted
to rule out if Noggin by itself had any effects on oligoden-
drocyte differentiation and/or enhanced survival. Neural
progenitor cells treated with 500 ng/ml Noggin alone in in-
sulin-free media did not display any enhanced differentiation
or survival effects. Finally, addition of 500 ng/ml Noggin to-
gether with 50 ng/ml BMP2 and 500 ng/ml IGF-I effi-
ciently reversed the inhibitory effects of BMP signaling on
oligodendrocyte differentiation (Fig. 5, G and H).
If IGF-I induction of oligodendrocyte differentiation in-
volves the inhibition of BMP signaling, a change in the ex-
pression of BMP antagonists upon IGF-I treatment might
be observed. In addition to extracellular antagonists of BMP
signaling, such as Noggin, intracellular proteins that can in-
terfere with downstream BMP receptor signaling, called in-
hibitory Smads (Smad6, Smad7), have also been identified
(Christian and Nakayama, 1999). Therefore, we performed
Q-PCR analysis of cultures treated with 500 ng/ml IGF-I
for 24 h and examined the relative fold change of Noggin,
Smad6, and Smad7 (Fig. 6; all values were normalized to ex-
pression levels under FGF-2 conditions). Expression of
Noggin and Smad6 increased by at least four- and sixfold,
respectively, after IGF-I treatment. There was only a slight
increase in Smad7 levels with IGF-I treatment ( 1.2-fold).
In each case, if IGF-I–treated cultures included 20 ng/ml
FGF-2, the up-regulation of BMP antagonists was not ob-
served, suggesting that FGF-2 can suppress the IGF-I–medi-
ated up-regulation of Noggin and Smad6. Together, these
results suggest that IGF-I–instructive effects on oligoden-
drocyte differentiation are mediated, at least in part, through
an inhibition of BMP signaling.
Effects of IGF-I on oligodendrocytes in vivo
Our findings raised the question of whether IGF-I also has
effects on oligodendrocyte differentiation in vivo in the re-
gion where adult hippocampal neural progenitor cells nor-
mally reside. Therefore, we used adeno-associated virus
Figure 5. IGF-I–mediated oligodendrocyte differ-
entiation involves an inhibition of BMP signaling. 
(A and B) Cells treated with 500 ng/ml IGF-I alone 
(A) or in combination with 50 ng/ml BMP2 (B). 
Cells were stained for an oligodendrocyte marker 
(RIP) and DAPI. (C) Quantification of RIP
  or cells 
treated with 500 ng/ml IGF-I alone or with different 
doses of BMP2 (0.05–50 ng/ml) in 4-d cultures. 
(D and E) Cells treated with 50 ng/ml IGF-I alone 
or in combination with 500 ng/ml Noggin. (F) 
Quantification of cells treated with different doses 
of IGF-I (20–1,000 ng/ml) alone (blue columns) or 
in conjunction with 500 ng/ml Noggin (black columns). Significant differences are indicated with an asterisk (P   0.05, t test). (G) Cells treated 
with a combination of IGF-I, BMP2, and Noggin. (H) Quantification of RIP
  cells in IGF-I alone, IGF-I   BMP2, and IGF-I   BMP2   Noggin. 
For G and H, concentrations are as follows: IGF-I, 500 ng/ml; BMP2, 50 ng/ml; Noggin, 500 ng/ml. Bar, 50  m. All error bars represent SDs.118 The Journal of Cell Biology | Volume 164, Number 1, 2004
(AAV) to overexpress IGF-I in the adult rat hippocampus.
To evaluate effects on the endogenous oligodendrocyte pop-
ulation due to IGF-I overexpression in vivo, we used the oli-
godendrocyte marker RIP. We focused our analyses on the
hilar region of the dentate gyrus because there is a higher
concentration of oligodendrocytes in this region. An in-
crease of RIP staining in the hilus of rAAV-IGF-I–infected
animals compared with rAAV- -gal–infected controls was
apparent (Fig. 7, A and E). Quantification of RIP immuno-
fluorescence in the hilus of rAAV- -gal–infected control an-
imals resulted in an average pixel intensity of 45.49   2.01
(n   3 rats), compared with an average pixel intensity of
99.95   18.27 (n   4 rats) in rAAV-IGF-I–infected ani-
mals (P   0.05, t test). Similar results were seen in at least
three adjacent fields of the same section.
A similar trend was observed using MBP immunofluores-
cence as a marker for mature oligodendrocytes. The extent
of MBP staining appeared more intense in the hilus of IGF-
I–infected animals compared with control animals (Fig. 7, B
and F). The average pixel intensity of MBP immunofluores-
cence in controls was 30.8   6.84 (n   3 rats) compared
with an average pixel intensity of 53.53   5.72 (n   4 rats)
in rAAV-IGF-I–infected animals (P   0.05, t test). There
was no observable difference in GFAP staining between con-
trol and IGF-I–infected animals, suggesting that there is not
a general increase in all glial cell lineages in animals overex-
pressing IGF-I (Fig. 7, C and G).
Because we observed an increase in overall staining for var-
ious oligodendrocyte markers (RIP and MBP) after IGF-I
overexpression in the adult hippocampus, we next deter-
mined if there was also a change in the number of oligoden-
drocytes. For quantification of oligodendrocytes, sections
were labeled for the   isoform of GST (GST- ). GST-  has
been determined in many experiments to label both imma-
ture and mature myelinating oligodendrocytes (Tansey and
Cammer, 1991; Mason et al., 2001), and facilitates cell
counting due to its predominant localization in oligoden-
drocyte cell bodies as well as in a few of the processes. The
average number of GST- –positive cells per section was
8.08   2.43 (n   3 rats) for rAAV- -gal control animals
and 29.14   5.04 (n   4 rats) for rAAV-IGF-I animals,
which is a threefold difference (Fig. 7, I–K; P   0.001, t
test). These results support that IGF-I is a regulator of oligo-
dendrocyte differentiation in vivo as well as in vitro.
Discussion
In this paper, we show that IGF-I, IGF-II, and insulin
could all independently stimulate the differentiation of
adult multipotent neural progenitor cells into oligodendro-
cytes. Modeling analysis reveals that IGF-I provides an
instructive (rather than a selective) regulation in oligo-
dendroglial fate choice. IGF-I–treated cultures also dem-
onstrate an increase in the proliferation of committed
oligodendrocytes. Moreover, the finding that IGF-I over-
expression in the adult hippocampus leads to an increase in
oligodendrocyte markers supports IGF-I effects in vitro.
To our knowledge, this is the first example of a single fac-
tor that can induce the robust differentiation of multipo-
tent neural progenitor cells into oligodendrocytes.
To address whether IGF-I effects are instructive and/or se-
lective in nature, we used both experimental and modeling
approaches. First, we addressed the question of whether
IGF-I might have selective effects on cell survival. Because
the frequency of cell death is low in IGF-I–treated cultures
and there is no significant difference in the percentage of
cells that are dying/dead at each of the time points analyzed,
it is unlikely that the net increase in oligodendrocytes by
IGF-I comes from the selective survival of committed oligo-
dendrocyte progenitors that then go on to differentiate. Al-
though there is massive cell death in the absence of IGF-I,
this cell death applies widely across all types of neural pro-
genitor cells. Treatment of cells with the broad caspase
inhibitor Q-VD-OPh further reinforced the finding that
IGF-I is not merely acting on cell survival. The addition of
Q-VD-OPh is enough for the cells to survive, and not to
proliferate or differentiate into definitive oligodendrocytes
in short-term cultures; only upon addition of IGF-I is there
a massive increase in oligodendrocyte differentiation.
Next, we addressed the question of selective effects on
cell proliferation by IGF-I. The BrdU analyses indicate
that there is not an increase in proliferation at time points
where oligodendrocyte differentiation is already occur-
ring, suggesting that a selective proliferation of progeni-
tors does not appear to make a major contribution to the
net oligodendrocyte increase. To address the possibility
that a robust differentiation effect by IGF-I might mask a
proliferation effect, a model was used to separate the inde-
pendent contributions of IGF-I on proliferation and dif-
ferentiation. The model-derived data showed an increase
in the rate of oligodendrocyte differentiation and not in
the proliferation rate of RIP
  progenitors. The model also
showed an increase in the proliferation rate of committed
oligodendrocytes in IGF-I–treated cultures. Therefore,
the simplest interpretation of our data is that IGF-I acts to
control the fate choice of multipotent adult neural pro-
genitor cells to an oligodendroglial lineage, and that the
net increase in oligodendrocytes by IGF-I is due to an in-
Figure 6. IGF-I induction of oligodendrocyte differentiation is 
associated with an up-regulation of BMP antagonists Noggin, Smad6, 
and Smad7. Q-PCR analysis and quantification of relative fold 
change (normalized to expression levels under FGF-2 conditions) 
of Noggin, Smad6, and Smad7. RNA was harvested from 24-h 
cultures treated with 20 ng/ml FGF-2, 500 ng/ml IGF-I, or both. All 
error bars represent SDs.Oligodendrocyte differentiation induced by IGF-I | Hsieh et al. 119
structive differentiation and an additional proliferation of
committed oligodendrocytes.
Recently, it has been reported that IGF-I can stimulate
neurogenesis in the dentate gyrus (Aberg et al., 2000), as
well as increase the proliferation and neuronal differentia-
tion of EGF-responsive multipotent neural stem cells de-
rived from E14 mouse striatum (Arsenijevic and Weiss,
1998; Arsenijevic et al., 2001). Although it is not clear
whether oligodendrocyte differentiation was examined in
these experiments, the possibility still remains that IGF-I
promotes the differentiation of multipotent neural progen-
itor cells to both neuronal and oligodendrocyte lineages.
In fact, our work shows that, in IGF-I–treated cultures, al-
though the majority of the cells differentiate into oligo-
dendrocytes, a small number of cells can differentiate into
neurons. Because small numbers of cells differentiate into
neurons, it was difficult to determine if the effects of IGF-I
on neuronal differentiation were instructive or selective
in nature, or whether a population of lineage-restricted
neuronal progenitors exists that could survive and differen-
tiate in the presence of IGF-I. Because we did not observe
an increase in astrocyte differentiation with IGF-I treat-
ment in vitro, or any apparent effects on the existing astro-
cyte population in vivo, it would appear that IGF-I effects
on neural progenitor cells are restricted, at least in part, to
oligodendrocyte and neuronal lineages. The possibility re-
mains that IGF-I could have instructive effects on astro-
glial fate commitment from a multipotent progenitor cell
population in vivo.
We hypothesized that oligodendrocyte differentiation of
multipotent adult neural progenitor cells might use similar
mechanisms as oligodendrocyte progenitors derived from
the embryonic brain and spinal cord, and that IGF-I in-
duction of oligodendrocyte differentiation might involve
an inhibition of BMP signaling. Our data suggest that
BMPs can repress IGF-I–induced oligodendrocyte differ-
entiation from adult neural progenitor cells. Furthermore,
addition of Noggin together with lower concentrations of
IGF-I results in a greater percentage of cells that differenti-
ate into oligodendrocytes compared with IGF-I alone, sug-
gesting that IGF-I induction of oligodendrocyte differenti-
ation involves the activation of BMP antagonists such as
Noggin. This finding, together with the observation that
there is an up-regulation of Noggin, Smad6, and Smad7
with IGF-I treatment, further reinforces the role of IGF-I
in the inhibition of BMP signaling to promote oligoden-
drocyte differentiation. A proposed model is shown in Fig.
8. BMP signaling has been shown to alter the fate of neural
progenitor cells by stimulating astroglial differentiation
while inhibiting neuronal and oligodendroglial differentia-
tion (Fig. 8 A; Mehler et al., 1997; Mabie et al., 1999; Na-
kashima et al., 2001). IGFs (IGF-I and -II) and/or insulin
Figure 7. IGF-I overexpression in the hilus promotes oligodendrocyte differentiation in vivo. (A–J) Representative images of brain sections 
focusing in on the hilar region in animals injected with rAAV- -gal controls (A–D and I) and rAAV-IGF-I (E–H and J). Sections were triple labeled 
with antibodies to oligodendrocyte markers RIP (A and E) and MBP (B and F), and an astrocyte marker GFAP (C and G). Merged images are 
shown in D and H; RIP is in red, MBP is in blue, GFAP is in green. (I and J) Representative sections stained with the oligodendrocyte marker 
GST-  in red and DAPI to visualize cell nuclei. White arrows indicate cells that are GST- –positive. (K) The average number of cells in the 
hilus (in three adjacent fields distal to the injection site) per section in which GST-  was detected in each animal group (rAAV- -gal animals, 
n   3; rAAV-IGF-I animals, n   4) is plotted. The asterisk indicates that values are significantly different between control and IGF-I–overexpressed 
animals (P   0.001, t test), and error bars represent SDs. Bar, 100  m.120 The Journal of Cell Biology | Volume 164, Number 1, 2004
activate IGF-I receptors located on multipotent neural
progenitor cells, which leads to the up-regulation of BMP
antagonists such as Noggin, Smad6, and Smad7. Because
Noggin, Smad6, and Smad7 inhibit BMP signaling, the
net effects of IGF signaling are a decrease or absence of as-
trocyte differentiation and an increase in neuronal and oli-
godendroglial differentiation (Fig. 8 B). Future analyses
are needed to determine whether all of the IGF-instructive
effects on oligodendrocyte differentiation occur through an
inhibition of BMP signaling, or if IGFs can directly pro-
mote oligodendroglial lineage commitment in a Noggin/
Smad6, Smad7-independent manner.
Although IGF-I overexpression in vivo mediates an in-
crease in oligodendrocyte markers, a finding that supports
IGF-I effects on neural progenitors in vitro, there are several
other possibilities that should be taken into consideration.
The increase in the number of GST- –positive cells could
be due to a general increase in cell number with IGF-I over-
expression in vivo; in fact, previous reports have indicated
that IGF-I transgenic mice have a general increase in cell
number that affects oligodendrocytes and nonoligodendro-
cytes equally, and that a change in the percentage of oligo-
dendrocytes was not found (Carson et al., 1993). Further
analyses are needed to determine if IGF-I affects the existing
oligodendrocyte population (maturation, survival) and/or
the multipotent stem or progenitor cell population (prolifer-
ation, fate choice). The differentiation of multipotent adult
neural progenitor cells likely depends on a complex interplay
of signals found in the local CNS environment. Our results
suggest that IGFs may represent a general class of molecules
that instruct multipotent neural progenitor cells to differen-
tiate into oligodendrocytes. Future work will be directed at
characterizing the mechanism of adult oligodendrocyte dif-
ferentiation and the nature of an oligodendrocyte niche in
different CNS environments.
Materials and methods
Cell culture and in vitro differentiation analysis
The neural progenitor cells isolated from the hippocampus of adult female
Fischer 344 rats used in this work have been characterized previously
(Gage et al., 1995; Palmer et al., 1997). The whole brain–derived neural
stem cells from P10 ICR mice were isolated and cultured according to the
methods as described, with slight modifications. Cells were cultured as de-
scribed previously (Ray et al., 1993; Gage et al., 1995). Cells between pas-
sages 10 and 20 were used for in vitro differentiation analyses. To induce
differentiation, cells were plated into 4-well chamber slides at a density of
55,000–75,000 cells/well and were allowed to proliferate in insulin-con-
taining N2-supplemented (Invitrogen) DME:Ham’s F12 (Omega Scientific)
medium containing 20 ng/ml FGF-2 (PeproTech, Inc.) for 24 h. FGF-2 was
then withdrawn and cells were subsequently treated with differentiation
media. Differentiation conditions were either N2 medium with 1  M RA
(Sigma-Aldrich) and 1% FBS (Omega Scientific) for 4 d (mixed); 1  M RA
and 5  M forskolin (Sigma-Aldrich) for 4 d (neuronal), or 50 ng/ml leuke-
mia inhibitory factor (CHEMICON International, Inc.) and 50 ng/ml BMP2
(R&D Systems) for 6 d (astrocytic; Nakashima et al., 1999). For IGF induc-
tion experiments, cells were trypsinized, washed with 1  PBS, and plated
into insulin-free N2 medium. Either 500 ng/ml human recombinant IGF-I
or IGF-II (R&D Systems) or 500 ng/ml insulin (Sigma-Aldrich) was added
for 4 d, except when indicated otherwise. In some cultures, 2.5  M BrdU
(Sigma-Aldrich) was added to label dividing cells, and 2  M Q-VD-OPh
(Enzyme Systems Products) was added to prevent apoptosis. Recombinant
mouse Noggin (R&D Systems) was added in some cultures to a final con-
centration of 500 ng/ml.
Immunocytochemistry and in vitro quantification
Cells were fixed with 4% PFA, followed by immunocytochemical staining
as described previously (Palmer et al., 1999). Labeled cells were visualized
using an upright microscope (model E800; Nikon) or an inverted micro-
scope (model E600; Nikon) and a CCD camera (Spot RT; Diagnostic Instru-
ments). DAPI was used to identify individual cells. Quantification of cell
phenotypes was with StereoInvestigator (MicroBrightfield Inc.); for each
marker, 500–1,000 cells were sampled systematically from standardized
fields at 40 . For quantification of live/dead cells, images were taken of
cultures live stained with 1  g/ml propidium iodide (Molecular Probes,
Inc.) and 1  g/ml Hoescht 33342 (Sigma-Aldrich) at 10 , and cells were
counted using Image-Pro (Media Cybernetics). Primary antibodies were
used as follows: rabbit anti-Tuj1 (1:7,500; Covance), mouse anti-RIP
(1:25–1:75; Developmental Studies Hybridoma Bank, Iowa City, IA); guinea
pig anti-GFAP (1:500–1:2,500; Advanced Immunochemical, Inc.); rabbit
Figure 8. Proposed model for the role of IGFs in multipotent neural progenitor cell fate specification: oligodendroglial and neuronal fate 
commitment at the expense of astroglial fates? (A) BMP signaling has been shown to stimulate astroglial differentiation and inhibit neuronal 
and oligodendroglial differentiation. (B) Activation of the IGF-I receptor on multipotent neural progenitor cells by IGFs leads to the up-regulation 
of Noggin, Smad6, and Smad7. Because Noggin, Smad6, and Smad7 inhibit BMP signaling, the net effects of IGF signaling are a block in 
astrocyte differentiation and an induction of neuronal and oligodendroglial differentiation. Alternatively, IGF-instructive effects on oligoden-
drocyte differentiation could occur in a Noggin/Smad6, Smad7-independent pathway.Oligodendrocyte differentiation induced by IGF-I | Hsieh et al. 121
anti-MBP (1:500; CHEMICON International, Inc.), mouse anti-O4 (1:2; hy-
bridoma supernatant from cells provided by O. Boegler, University of Cal-
ifornia, San Diego, San Diego, CA), rat anti-BrdU (1:400; Accurate). Sec-
ondary antibodies were all purchased from Jackson ImmunoResearch
Laboratories and used at 1:250 dilution. The detection of BrdU in cultured
cells required treatment in 2N HCL at 37 C for 30 min (Palmer et al.,
1999). All experiments were independently replicated at least three times.
IGF-I overexpression in vivo and quantification
cDNA encoding the human IGF-I gene was cloned into a recombinant
AAV vector and the virus was prepared as described previously (Kaspar et
al., 2002). Expression of IGF-I and  -gal (control AAV) was first confirmed
in human embryonic kidney (HEK-293) cells by RT-PCR and Western anal-
ysis and subsequently in the hippocampus by RT-PCR analysis (unpub-
lished data). Recombinant AAV-IGF-I (rAAV-IGF-I) or AAV- -gal (rAAV-
 -gal) was stereotaxically injected into the hippocampus (anteroposterior
axis,  4.0 mm; mediolateral axis,  2.0 mm; dorsoventral axis,  3.0 from
skull, with nose bar at 3.3 mm up) of anesthetized female Fischer-344 rats
(150–175 g; n   6). After 4 wk to allow for virus processing and transgene
expression, animals were killed. Animals were perfused with 4% PFA and
the brains were excised, stored in fixative overnight, and transferred to
30% sucrose. 40- m coronal sections were cut on a sliding microtome,
and sections were processed for standard immunohistochemical staining
as described previously (Gage et al., 1995). Sections were triple labeled
with mouse anti-RIP (1:50), rabbit anti-MBP (1:500), and guinea pig anti-
GFAP (1:1,000). In some cases, sections were labeled with mouse anti-
GST-  (1:100; BD Biosciences). Images were acquired using a confocal
microscope (Radiance 2100; Bio-Rad Laboratories) and an inverted micro-
scope (model TE2000; Nikon) equipped with a 40  NA 1.3 Plan Fluor ob-
jective lens. Images were post processed using Adobe PhotoShop
®.
All comparative analyses were focused on the hilus of the injected side
on matched hippocampal sections. For RIP or MBP staining, immunofluo-
rescence average pixel intensity of equivalent-sized fields (four from each
animal) in control and experimental groups was determined from digital
images using Adobe Photoshop
®. To quantify the number of oligodendro-
cytes, sections were immunostained with GST- . Only immunolabeled
cells with a clear DAPI-positive nucleus were scored. For quantification of
GST-  cells, area counts of the hilus within the dentate gyrus of the hippo-
campus were performed. In each section, three adjacent fields were sam-
pled. Cells in the uppermost focal plane were ignored, and we focused
through the thickness of the section to avoid errors caused by oversam-
pling. The results are expressed as the average number of cells per section.
Quantitative real-time PCR analysis
Total RNA was isolated from cell cultures using RNeasy columns (QIA-
GEN). For real-time quantitative PCR, reactions were performed essentially
as described previously (Zhao et al., 2001). The relative amount of the
tested message was normalized to the level of the internal control mes-
sage, GAPDH. Furthermore, independent experiments were performed
with a different internal control message,  -actin, and showed similar re-
sults. Primer sequences are available upon request.
Statistics
Results were analyzed for statistical significance using t test or by ANOVA,
and all error bars (except in Fig. 3, D and E) are expressed as SDs. Post-hoc
analysis was done using Bonferroni corrected planned comparison.
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